Delivery Order SPE2DB20D1109-SPE2DB25FN37L
Award Date
1/8/25
Potential Completion Date
1/9/25
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $89,213.41 firm-fixed-price contract is for the delivery of 4558604312 - ACTIVASE 100 MG VIALS, a medical product used for patient care. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The fixed-price contract, valued at $11,344.63, has a period of performance through November 13, 2024.
The contract does not have a set-aside designation, indicating open competition. As a large pharmaceutical distributor, AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $83,574.45 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a specialized medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024.
Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $26,175.31 firm-fixed-price contract is for the delivery of ACTIVASE 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of August 28, 2024.
AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical supplies and pharmaceuticals to various...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The $5,713.85 firm fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The $58,802.81 firm fixed-price contract is for the supply of 4565108834 ACTIVASE 100 MG VIALS.
Amerisourcebergen, a leading pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,141.52 Firm Fixed Price Delivery Order is for the supply of ACTIVASE 100 MG VIALS, a specialty pharmaceutical product. The contract has a period of performance through November 1, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The award, valued at $57,118.47, is a firm fixed-price contract with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which allows the...
This is a $7,844.87 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100mg vials of the drug Activase. The contract has a completion date of September 18, 2024 and is not a set-aside award. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for providing a comprehensive...
This federal contract award is for the delivery of 4566518759 ACTIVASE 100 MG VIALS to the Defense Logistics Agency (DLA). The $19,759.06 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 21, 2024, with a completion date of November 22, 2024. The contract is not designated under any set-aside program.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...